G.ShaoH.SinghO
For individuals with obesity-related health conditions such as type 2 diabetes, PCOS, high blood pressure, cardiovascular disease, or non-alcoholic fatty liver disease (NAFLD), weight management therapies such as GLP-1s can be an essential component of comprehensive treatment plans aimed at reducing disease and improving overall health
Despite the overall growth in the diabetes market, sales of Byetta steadily declined to $254 million (5.1% market share) in 2016 and $176 (2.7% market share) in 2017 (Figure 7, Table 5) due to competition from other safer and more convenient GLP-1 RAs
By respecting the shelf life of your medication, you ensure that every dose you take is working at its full potential to help you reach your goals
This can worsen constipation rather than relieve it
Many patients start noticing changes in appetite within the first week and observe measurable weight loss by week four